NCT04804696 2025-02-21
Toripalimab with Paclitaxel and Cisplatin As Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma
Peking University
Phase 2 Terminated
Peking University
Boston Scientific Corporation
National Cancer Institute (NCI)
AIO-Studien-gGmbH
Japan Clinical Oncology Group
SWOG Cancer Research Network
Northwestern University